Lumida
/CARL
⌘K
CARL

CARL

CARL
$14.73USD↓-0.20%-0.03 today

MARKET CAP

402.2M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$15 – $15

52W RANGE

$9
$17

AI Summary

Stalk
TrimMedium

CARL remains in a Stage 4 Decline with confirmed lower highs and lower lows. Price trades below all major EMAs, which are sloping down and acting as resistance. The medium-term bias is bearish, reinforced by the absence of any active bullish patterns and persistent distribution pressure. On the short term, price is extended below EMAs without a clear pullback into resistance, creating no immediate entry edge. Execution should be deferred until a retest of falling EMAs or structural resistance offers a better setup for bearish engagement.

  • ↑Q2 revenue +57% YoY to $18.9M; full-year guide upped to $74–78M
  • ↑Gross margin rose to 76.8% from 73.4% on efficiency gains
  • ↓GAAP net loss widened to $10.5M vs $6.8M last year
Full analysis →

Buying

6

institutions

Selling

1

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
JH

Janus Henderson Group Plc

Q1 2026

BUY2.45 M22.22 M+1.31 M+57.7%0.01%
BI

Blackrock, Inc.

Q2 2026

BUY532.59 K5.53 M+85.70 K+36.7%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW295.91 K3.07 M+295.91 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY101.73 K1.06 M+57.13 K+161.6%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW92.16 K956.61 K+92.16 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY5.26 K58.53 K+201.00+25.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-10.40 K-100.0%0.00%